Medical use of tectorigenin in treatment of chicken necrotic enteritis
US11491135B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 14, 2019 |
| Grant date | Nov 8, 2022 |
| Priority date | — |
| Expiry date | Nov 9, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is use of tectorigenin in the preparation of a medicament for treatment of chicken necrotic enteritis. Using tectorigenin for treating chicken necrotic enteritis can significantly reduce the degree of pathological changes in the intestinal tract of chickens with necrotic enteritis, and has a good therapeutic effect on chicken necrotic enteritis caused by Clostridium perfringens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.